First Trust NYSE Arca Biotechnology Index Fund
112 hedge funds and large institutions have $1.32B invested in First Trust NYSE Arca Biotechnology Index Fund in 2014 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 47 increasing their positions, 33 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
14% more funds holding
Funds holding: 98 → 112 (+14)
2.37% more ownership
Funds ownership: 57.99% → 60.36% (+2.4%)
45% less call options, than puts
Call options by funds: $918K | Put options by funds: $1.68M
Holders
112
Holding in Top 10
6
Calls
$918K
Puts
$1.68M
Top Buyers
| 1 | +$165M | |
| 2 | +$29.5M | |
| 3 | +$22.3M | |
| 4 |
NCM
Niemann Capital Management
Stateline,
Nevada
|
+$6.01M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$4.48M |
Top Sellers
| 1 | -$15.5M | |
| 2 | -$3.97M | |
| 3 | -$3.26M | |
| 4 |
JPMorgan Chase & Co
New York
|
-$2.31M |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$2.06M |